CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 2, 2008, Pages 181-188

  Beeler, A ^a   Zaccaria, L ^a   Kawabata, T ^b   Gerber, B O ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b PFIZER INC   (United States)

Author keywords

CD69 upregulation; Drug hypersensitivity; In vitro diagnosis; Lymphocyte transformation test; T cells

Indexed keywords

AMOXICILLIN; AMPICILLIN; CARBAMAZEPINE; CD69 ANTIGEN; CEFUROXIME; CLAVULANIC ACID; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; MOXIFLOXACIN; PHENYTOIN; SULFAMETHOXAZOLE; SULFAPYRIDINE; VANCOMYCIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE TRANSFORMATION TEST; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; UP-REGULATION;

EID: 37749048434     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01516.x     Document Type: Article

References (31)

1. Sainte-Laudy J, Vallon C, Guerin JC. Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis. Allerg Immunol (Paris) 1994 26 : 211 214.
2. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy 2004 34 : 332 339.
3. Hoigne R, Schlumberger HP, Vervloet D, Zoppi M. Epidemiology of allergic drug reactions. Monogr. Allergy 1993 31 : 147 170.
4. Yawalkar N, Hari Y, Frutig K, Egli F, Wendland T, Braathen LR et al. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 2000 115 : 647 652.
5. Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 2004 194 : 179 196.
6. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003 111 : 1393 1403.
7. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001 31 : 1398 1408.
8. Zanni MP, von Greyerz S, Schnyder B, Mauri-Hellweg D, Brander C, Kalbermatten C et al. T cell reactions in patients showing adverse immune reactions to drugs. Inflamm Res 1996 45 (Suppl 2 S79 S84.
9. Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S. Role of T cells in drug allergies. Allergy 1998 53 : 225 232.
10. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995 155 : 2670 2678.
11. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997 27 : 175 181.
12. Luque I, Leyva L, Jose Torres M, Rosal M, Mayorga C, Segura JM et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001 56 : 611 618.
13. Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006 117 : 455 462.
14. Beeler A, Pichler WJ. In vitro tests of T cell mediated drug hypersensitivity. Expert Rev Clin Immunol 2006 2 : 887 900.
15. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004 59 : 809 820.
16. Hertl M, Geisel J, Boecker C, Merk HF. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br J Dermatol 1993 128 : 619 626.
17. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001 107 : 1433 1441.
18. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995 155 : 462 472.
19. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E et al. Characterization of lidocaine-specific T cells. J Immunol 1997 158 : 1139 1148.
20. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blomeke B. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 2002 109 : 1005 1011.
21. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006 36 : 59 69.
22. Everness KM, Gawkrodger DJ, Botham PA, Hunter JA. The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test. Br J Dermatol 1990 122 : 293 298.
23. Warrington RJ, Tse KS. Lymphocyte transformation studies in drug hypersensitivity. Can Med Assoc J 1979 120 : 1089 1094.
24. Barna BP, Gogate P, Deodhar SD, Moeder M. Lymphocyte transformation and radioallergenosorbent tests in drug hypersensitivity. Am Soc Clin Pathol 1980 1980 : 172 176.
25. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003 63 : 732 741.
26. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995 20 : 127 133.
27. Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E et al. Terminology of contact dermatitis. Acta Derm Venereol 1970 50 : 287 292.
28. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm 2001 45 : 321 328.
29. Wu Y, Farrell J, Pirmohamed M, Park BK, Naisbitt DJ. Generation and characterization of antigen-specific CD4(+), CD8(+), and CD4(+)CD8(+) T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol 2007 119 : 973 981.
30. Vanham G, Kestens L, Vingerhoets J, Penne G, Colebunders R, Vandenbruaene M et al. The interleukin-2 receptor subunit expression and function on peripheral blood lymphocytes from HIV-infected and control persons. Clin Immunol Immunopathol 1994 71 : 60 68.
31. Adkinson NF Jr., Essayan D, Gruchalla R, Haggerty H, Kawabata T, Sandler JD et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol 2002 109 : S461 S478.